Squarepoint Ops LLC Veracyte, Inc. Transaction History

Squarepoint Ops LLC

$93.7 Billion
Q2 2025

A detailed history of Squarepoint Ops LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 897,387 shares of VCYT stock, worth $25.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

897,387

Previous 103,080 770.57%

Holding current value

$25.8 Million

Previous $3.06 Million 693.72%

% of portfolio

0.03%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$26.39 - $32.62 $21 Million - $25.9 Million	794,307 Added 770.57%	897,387 $24.3 Million
Q1 2025 May 15, 2025	BUY	$29.65 - $46.14 $2.88 Million - $4.48 Million	97,104 Added 1624.9%	103,080 $3.06 Million
Q4 2024 Feb 14, 2025	SELL	$31.92 - $44.4 $963,090 - $1.34 Million	-30,172 Reduced 83.47%	5,976 $236,000
Q3 2024 Nov 14, 2024	BUY	$21.0 - $35.25 $759,108 - $1.27 Million	36,148 New	36,148 $1.23 Million
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $71,064 - $98,474	3,384 Added 2.44%	142,227 $3.15 Million
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $2.74 Million - $3.98 Million	138,843 New	138,843 $3.82 Million
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $2.62 Million - $3.55 Million	127,331 New	127,331 $2.84 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $1.06 Million - $1.79 Million	64,217 New	64,217 $1.07 Million
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $510,398 - $759,007	-14,329 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $237,925 - $408,966	7,223 Added 101.65%	14,329 $573,000
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $604,080 - $1.11 Million	-13,584 Reduced 65.65%	7,106 $382,000
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $405,930 - $773,128	12,494 Added 152.44%	20,690 $1.01 Million
Q3 2020 Nov 16, 2020	SELL	$26.73 - $35.67 $87,219 - $116,391	-3,263 Reduced 28.48%	8,196 $266,000
Q2 2020 Aug 14, 2020	SELL	$19.49 - $28.11 $96,085 - $138,582	-4,930 Reduced 30.08%	11,459 $297,000
Q1 2020 May 15, 2020	SELL	$16.13 - $30.17 $1.8 Million - $3.37 Million	-111,591 Reduced 87.19%	16,389 $398,000
Q4 2019 Feb 14, 2020	BUY	$20.78 - $29.99 $626,994 - $904,888	30,173 Added 30.85%	127,980 $3.57 Million
Q3 2019 Nov 14, 2019	SELL	$23.87 - $30.93 $133,504 - $172,991	-5,593 Reduced 5.41%	97,807 $2.35 Million
Q2 2019 Aug 14, 2019	SELL	$22.1 - $28.56 $2.15 Million - $2.78 Million	-97,367 Reduced 48.5%	103,400 $2.95 Million
Q1 2019 May 15, 2019	BUY	$12.0 - $25.76 $1.06 Million - $2.28 Million	88,626 Added 79.03%	200,767 $5.02 Million
Q4 2018 Feb 14, 2019	BUY	$9.15 - $14.85 $77,171 - $125,244	8,434 Added 8.13%	112,141 $1.41 Million
Q3 2018 Nov 14, 2018	BUY	$9.55 - $12.64 $512,682 - $678,565	53,684 Added 107.32%	103,707 $990,000
Q2 2018 Aug 14, 2018	BUY	$5.39 - $9.66 $55,101 - $98,754	10,223 Added 25.69%	50,023 $467,000
Q1 2018 May 15, 2018	SELL	$5.44 - $6.97 $47,697 - $61,112	-8,768 Reduced 18.05%	39,800 $221,000
Q4 2017 Feb 14, 2018	SELL	$6.05 - $9.37 $6,848 - $10,606	-1,132 Reduced 2.28%	48,568 $317,000
Q3 2017 Nov 14, 2017	BUY	$7.81 - $8.77 $388,157 - $435,869	49,700	49,700 $436,000

Others Institutions Holding VCYT

# of Institutions

297

Shares Held

77.5M

Call Options Held

Put Options Held

17.6K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.06B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Veracyte, Inc. Transaction History